Hemogenyx Pharmaceuticals plc announced that Andrew Wright has been appointed as Financial Controller & Company Secretary, a non-Board position, and that Lawrence Pemble, Chief Operating Officer, will step down from the Board, both with immediate effect. Andrew began his career in audit at PricewaterhouseCoopers and has an MBA in Finance and Strategy from the UCLA Anderson School of Management in Los Angeles, USA. He serves as Director of Corporate Development and Technology for Thomas Murray, a post-trade capital markets data and advisory firm. Andrew is also an Executive Director of Trayned Insight Ltd, a data science company serving the healthcare and pharmaceutical industries.